Literature DB >> 22687378

Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.

Yaojun Zhang1, Jia Huang, MinShan Chen, Long R Jiao.   

Abstract

OBJECTIVES: Vascular invasion (VI) is the most important factor in assessing operability for pancreatic cancer. The accuracy of preoperative vascular staging with computed tomography (CT) and magnetic resonance imaging (MRI) was examined using meta-analysis.
METHODS: Published articles in pancreatic cancer comparing diagnostic accuracy of CT with MRI for VI confirmed on histology were searched from MEDLINE, EMBASE and ISI Web of Science databases. Pooled sensitivity, specificity, likelihood ratio, summary receiver operating characteristic (SROC) curve and area under curve (AUC) were analysed by SPSS 13.0 and Revmen 5.1.
RESULTS: Eight studies (n = 296) met the inclusion criteria. The pooled sensitivity of CT and MRI in diagnosing VI was 71% (95% CI, 64-78) and 67% (95% CI, 59-74), pooled specificity 92% (95% CI, 89-95) and 94% (95% CI, 91-96), positive likelihood ratio 6.33 (95% CI, 4.51-8.87) and 6.58 (95% CI, 4.62-9.37), negative likelihood ratio 0.34 (95% CI, 0.27-0.43) and 0.38 (95% CI, 0.30-0.47), and AUCs 0.87 and 0.76 (p = 0.63), respectively. There was no significant difference between CT and MRI for preoperative diagnosis of VI. Subgroup analysis of 4 studies (n = 143) showed no significant difference between CT and MRI in preoperative diagnosis of venous or arterial invasion (p = 0.73 and p = 0.81, respectively). When CT was compared with MRA in 3 studies (n = 110), again there was no significant difference for preoperative staging of VI (p = 0.54).
CONCLUSIONS: Both CT and MRI are underreporting vascular invasion preoperatively in pancreatic cancer. MRA does not add any additional information on vascular staging when compared with CT and MRI. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22687378     DOI: 10.1016/j.pan.2012.03.057

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  9 in total

1.  Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability.

Authors:  Vyacheslav I Egorov; Roman V Petrov; Elena N Solodinina; Gregory G Karmazanovsky; Natalia S Starostina; Natalia A Kuruschkina
Journal:  World J Gastrointest Surg       Date:  2013-04-27

2.  Locally advanced pancreatic cancer: open questions on terminology, diagnosis and management.

Authors:  Riccardo Casadei; Claudio Ricci; Francesco Minni
Journal:  Updates Surg       Date:  2014-06-26

3.  Response evaluation following neoadjuvant treatment of pancreatic cancer patients.

Authors:  Chiara Tosolini; Christoph W Michalski; Jörg Kleeff
Journal:  World J Gastrointest Surg       Date:  2013-02-27

4.  Endoscopic Ultrasonography for Vascular Invasion in Pancreatic Cancer.

Authors:  Seong-Hun Kim
Journal:  Clin Endosc       Date:  2019-08-13

5.  Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer.

Authors:  Yuki Fujii; Kazuyuki Matsumoto; Hironari Kato; Yosuke Saragai; Saimon Takada; Sho Mizukawa; Shinichiro Muro; Daisuke Uchida; Takeshi Tomoda; Shigeru Horiguchi; Noriyuki Tanaka; Hiroyuki Okada
Journal:  Clin Endosc       Date:  2019-05-16

6.  Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis.

Authors:  Felix G Gassert; Sebastian Ziegelmayer; Johanna Luitjens; Florian T Gassert; Fabian Tollens; Johann Rink; Marcus R Makowski; Johannes Rübenthaler; Matthias F Froelich
Journal:  Eur Radiol       Date:  2021-11-27       Impact factor: 7.034

7.  The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012.

Authors:  Johannes Czernin; Ken Herrmann
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

8.  Clinical predictors of resectability of pancreatic adenocarcinoma.

Authors:  Majid A Almadi; Othman Alharbi; Nahla Azzam; Mohannad Altayeb; Moammed Javed; Faisal Alsaif; Mazen Hassanain; Abdulsalam Alsharabi; Khalid Al-Saleh; Abdulrahman M Aljebreen
Journal:  Saudi J Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 2.485

Review 9.  Endoscopic ultrasound (EUS) and the management of pancreatic cancer.

Authors:  Muhammad Nadeem Yousaf; Fizah S Chaudhary; Amrat Ehsan; Alejandro L Suarez; Thiruvengadam Muniraj; Priya Jamidar; Harry R Aslanian; James J Farrell
Journal:  BMJ Open Gastroenterol       Date:  2020-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.